🎁
DIWALI SPECIAL

20% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

GENCON vs OMAXE: Stock Comparison

GENERIC ENG CONS PROJ vs OMAXEUpdated 30 Oct 26, 9:16 AM ISTNSE & company filings

OMAXE is the larger company by market capitalisation. GENERIC ENG CONS PROJ shows a higher ROE, faster revenue growth and lower leverage, while OMAXE shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GENCON leads 7; OMAXE leads 3 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GENCONOMAXE

Valuation lens

What price are you paying?

Market CapContext only
₹147 Cr
₹1,725 Cr
P/E RatioOMAXE has the lower reading
17.37x
0x ✓
P/B RatioOMAXE has the lower reading
0.77x
-1.87x ✓
EPSGENCON has the higher reading
₹1.5 ✓
₹0.05
Book ValueContext only
₹52.7
₹36.41
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
OMAXE is the larger company
₹1,725 Cr vs ₹147 Cr
P/E Ratio
OMAXE has a lower P/E
0x vs 17.37x
P/B Ratio
OMAXE has a lower P/B
-1.87x vs 0.77x
EPS
GENCON has higher earnings per share
₹1.5 vs ₹0.05
Revenue Growth (TTM YoY)
GENCON has faster revenue growth
-13.6% vs -35.6%
EPS Growth (TTM YoY)
OMAXE has faster EPS growth
0% vs -18.9%
ROE
GENCON has a higher ROE
2.9% vs -42.42%
ROCE
GENCON has a higher ROCE
4.35% vs -12.49%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGENCONOMAXE
SectorRealtyRealty
IndustryResidential Commercial ProjectsResidential Commercial Projects

Price

MetricGENCONOMAXE
Live Price₹26.11₹95.57
Day Change1.99%0.03%
Volume246,139
52-Week High₹59.96₹138.89
52-Week Low₹22.52₹62.5
Distance from 52W High-56.45%-31.19%

Valuation

MetricGENCONOMAXE
Market Cap₹147 Cr₹1,725 Cr
P/E Ratio17.37x0x
P/B Ratio0.77x-1.87x
EPS₹1.5₹0.05
Book Value₹52.7₹36.41
Dividend Yield0%0%

Growth

MetricGENCONOMAXE
Revenue Growth (TTM YoY)-13.6%-35.6%
EPS Growth (TTM YoY)-18.9%0%
Qtr Sales Growth0%0%
Qtr Profit Growth0%0%

Profitability & Leverage

MetricGENCONOMAXE
ROE2.9%-42.42%
ROCE4.35%-12.49%
Net Margin4.26%-55.6%
Operating Margin8.24%-22.34%
Debt to Equity0.2x1.04x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricGENCONOMAXE
Promoter Holding40.3%74.14%
FII Holding0.64%▲ 0.3 pp4.59%▼ 0.74 pp
DII Holding0.08%▲ 0.08 pp0.86%▼ 0.54 pp
Public Holding58.97%▼ 0.39 pp20.4%▲ 1.27 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GENERIC ENG CONS PROJ and OMAXE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.